Get the Stockscreener App
3.90
57.84%
-5.35
Pre-market:
4.01
0.11
+2.82%
Embecta Corp stock is traded at $3.90, with a volume of 15.99M.
It is down -57.84% in the last 24 hours and down -55.93% over the past month.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
See More
Previous Close:
$9.25
Open:
$5.065
24h Volume:
15.99M
Relative Volume:
14.58
Market Cap:
$230.96M
Revenue:
$1.08B
Net Income/Loss:
$139.50M
P/E Ratio:
1.6445
EPS:
2.3715
Net Cash Flow:
$205.80M
1W Performance:
-56.81%
1M Performance:
-55.93%
6M Performance:
-71.86%
1Y Performance:
-68.70%
1-Day Range:
$3.89
$5.11
1-Week Range:
$3.89
$9.43
52-Week Range:
$3.89
$15.55
Embecta Corp Stock (EMBC) Company Profile
Name
Embecta Corp
Sector
Industry
Phone
(862) 401-0000
Address
300 KIMBALL DRIVE, PARSIPPANY
Compare EMBC vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
3.90 | 230.96M | 1.08B | 139.50M | 205.80M | 2.3715 |
ISRG
Intuitive Surgical Inc
|
451.38 | 159.86B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.01B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.32 | 38.32B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.45 | 36.29B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
207.88 | 30.15B | 5.40B | 1.49B | 1.78B | 10.12 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-27-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | Wolfe Research | Peer Perform |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Sep-08-22 | Initiated | BTIG Research | Neutral |
| Aug-01-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-21-22 | Initiated | BofA Securities | Underperform |
View All
Embecta Corp Stock (EMBC) Latest News
Mizuho cuts Embecta stock price target on weak US sales performance - Investing.com
Why Embecta stock plummeted today - MSN
Embecta (EMBC) Margin Expansion To 12.9% Tests Bearish Earnings Sustainability Narrative - simplywall.st
Embecta’s Earnings Call: Growth Bets Amid Sharp Setback - TipRanks
Why Embecta Stock Plummeted Today - The Motley Fool
Why Embecta Stock Plummeted Today - The Motley Fool
Embecta declares $0.01 quarterly dividend payable June 15 By Investing.com - Investing.com Australia
Embecta Q2 2026 Earnings Call Transcript - MarketBeat
Embecta Cuts FY26 View To Rev $1.02B-$1.04B >EMBC - Moomoo
BTIG downgrades Embecta stock rating on U.S. market share loss - Investing.com
Embecta Corp. Q2 2026 Earnings Call Summary - Yahoo Finance
Embecta (EMBC) Q2 2026 Earnings Transcript - AOL.com
Yacktman Asset Mgmt, AMG Yacktman Fund Report Stakes in Embecta (EMBC) - Stock Titan
Embecta ‘disappointed’ with Q2 results that fell below expectations, cuts 2026 guidance - Drug Delivery Business
Embecta forecasts $1.015B-$1.035B FY 2026 revenue while launching $100M buyback and cutting dividend to $0.01 - MSN
Embecta (NASDAQ: EMBC) revenue drops as debt, buyback and Owen Mumford deal reshape 2026 - Stock Titan
Embecta Corp. announces an Equity Buyback for $100 million worth of its shares. - marketscreener.com
Embecta Q2 Earnings Call Highlights - MarketBeat
Embecta declares $0.01 quarterly dividend payable June 15 - Investing.com UK
Press Release: Embecta Announces Quarterly Cash Dividend - Moomoo
Embecta Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Embecta Q2 FY2026 slides: sharp miss triggers guidance cut, stock plunge - Investing.com
Embecta Corp. (NASDAQ:EMBC) Plunges Over 25% on Q2 Fiscal 2026 Miss - ChartMill
Guidance cut, buyback and dividend reduction at Embecta (Nasdaq: EMBC) - Stock Titan
EMBECTA ($EMBC) Releases Q2 2026 Earnings - Quiver Quantitative
embecta Announces Quarterly Cash Dividend - The Manila Times
embecta shareholders on record by May 28 get June 15 payout - Stock Titan
Embecta posts fiscal Q2 results, investor webcast starts at 8 a.m. ET - Stock Titan
Embecta Announces Quarterly Cash Dividend - marketscreener.com
EMBCEmbecta Corp Stock Price and Quote - Finviz
Embecta to hold second quarter fiscal year 2026 earnings call at 8 am ET - Traders Union
Universal Beteiligungs und Servicegesellschaft mbH Purchases 131,320 Shares of Embecta Corp. $EMBC - MarketBeat
Embecta Corp. (EMBC) amendment: American Century/ Stowers report 5.8% stakes - Stock Titan
EMBC Forecast, Price Target & Analyst Ratings | EMBECTA CORP (NASDAQ:EMBC) - ChartMill
Embecta Corp. authorizes a Buyback Plan. - marketscreener.com
Analyst Reiterates Buy on Embecta, Maintains $22 Price Target Amid Core Strength and Platform Expansion - TipRanks
How The Embecta (EMBC) Story Is Shifting As Targets Trim While Fair Value Holds - Yahoo Finance
Earnings Preview: Embecta to Report Financial Results Pre-market on May 05 - Moomoo
Vanguard Capital Management (EMBC) reports 5.07% stake in Embecta Corp - Stock Titan
Under the Radar: Why "Fixing" a Great Strategy Usually Breaks It - Benzinga
Embecta (EMBC) to Release Quarterly Earnings on Tuesday - MarketBeat
How Embecta Corp. (EMBC) Affects Rotational Strategy Timing - Stock Traders Daily
Embecta outlines $1.71B–$1.93B revenue target for 2026 as GLP-1 partnerships gain traction - MSN
Embecta Corp. $EMBC Shares Sold by State of Alaska Department of Revenue - MarketBeat
Embecta to Report Fiscal Second Quarter Financial Results - 富途牛牛
EMBC (Embecta Corp.) delivers narrow Q1 2026 EPS beat, shares dip slightly on soft year over year revenue results.Liquidity Risk - Xã Thanh Hà
EMBC (Embecta Corp.) delivers Q1 2026 earnings above expectations, shares climb as investors overlook mild yearly revenue declines.Trading Community - Cổng thông tin điện tử tỉnh Tây Ninh
embecta to Report Fiscal Second Quarter Financial Results - Sahm
Embecta Corp. to Host Conference Call Discussing Q2 2026 Financial Results and Operational Update - Quiver Quantitative
Embecta Corp Stock (EMBC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.78%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):